Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean J Barbour

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|February 22, 2020
Socioeconomic Position and Incidence of Glomerular DiseasesMark Canney, Dilshani Induruwage, Anahat Sahota, et al.
Clinical Kidney Journal|September 22, 2025
Novel therapies improve prognosis of IgAN and limit the applicability of the International IgA Nephropathy Prediction ToolXue Shen, Pei Chen, Lijun Liu, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2022
A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 VaccinationMark Canney, Mohammad Atiquzzaman, Amanda M Cunningham, et al.
Kidney International|November 8, 2024
Evaluating the risk of cardiovascular events associated with different immunosuppression treatments for glomerular diseasesMark Canney, Mohammad Atiquzzaman, Yuyan Zheng, et al.
Kidney International Reports|October 26, 2020
External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian CohortYuemiao Zhang, Ling Guo, Zi Wang, et al.
Kidney International|June 7, 2013
Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal diseaseSean J Barbour, Daniel C Cattran, S Joseph Kim, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 6, 2022
The Risk of Cardiovascular Events in Individuals With Primary Glomerular DiseasesMark Canney, Heather M Gunning, Yuyan Zheng, et al.
Glomerular Diseases|December 12, 2025
Evaluation of Biopsy-Based Molecular Risk Prediction in Crescentic GlomerulonephritisBenjamin A Adam, Kristalee Watson, Arashdeep Saini, et al.
Kidney International|January 14, 2016
The MEST score provides earlier risk prediction in lgA nephropathySean J Barbour, Gabriela Espino-Hernandez, Heather N Reich, et al.
Kidney International|May 1, 2022
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsySean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Clinical Journal of the American Society of Nephrology : CJASN|February 22, 2020
Socioeconomic Position and Incidence of Glomerular DiseasesMark Canney, Dilshani Induruwage, Anahat Sahota, et al.
Clinical Kidney Journal|September 22, 2025
Novel therapies improve prognosis of IgAN and limit the applicability of the International IgA Nephropathy Prediction ToolXue Shen, Pei Chen, Lijun Liu, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2022
A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 VaccinationMark Canney, Mohammad Atiquzzaman, Amanda M Cunningham, et al.
Kidney International|November 8, 2024
Evaluating the risk of cardiovascular events associated with different immunosuppression treatments for glomerular diseasesMark Canney, Mohammad Atiquzzaman, Yuyan Zheng, et al.
Kidney International Reports|October 26, 2020
External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian CohortYuemiao Zhang, Ling Guo, Zi Wang, et al.
Kidney International|June 7, 2013
Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal diseaseSean J Barbour, Daniel C Cattran, S Joseph Kim, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 6, 2022
The Risk of Cardiovascular Events in Individuals With Primary Glomerular DiseasesMark Canney, Heather M Gunning, Yuyan Zheng, et al.
Glomerular Diseases|December 12, 2025
Evaluation of Biopsy-Based Molecular Risk Prediction in Crescentic GlomerulonephritisBenjamin A Adam, Kristalee Watson, Arashdeep Saini, et al.
Kidney International|January 14, 2016
The MEST score provides earlier risk prediction in lgA nephropathySean J Barbour, Gabriela Espino-Hernandez, Heather N Reich, et al.
Kidney International|May 1, 2022
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsySean J Barbour, Rosanna Coppo, Hong Zhang, et al.
Pageof 7